CHF133.40
1.77% yesterday
SIX Swiss Exchange, Jun 13, 05:31 pm CET
ISIN
CH0468525222
Symbol
MOVE
Sector

Medacta Stock price

CHF133.40
-6.60 4.71% 1M
+22.80 20.61% 6M
+26.80 25.14% YTD
+6.20 4.87% 1Y
+53.40 66.75% 5Y
+37.30 38.81% 10Y
+37.30 38.81% 20Y
SIX Swiss Exchange, Closing price Fri, Jun 13 2025
-2.40 1.77%
ISIN
CH0468525222
Symbol
MOVE
Sector

Key metrics

Market capitalization CHF2.76b
Enterprise Value CHF2.96b
P/E (TTM) P/E ratio 39.59
EV/FCF (TTM) EV/FCF 1,286.37
EV/Sales (TTM) EV/Sales 5.33
P/S ratio (TTM) P/S ratio 4.98
P/B ratio (TTM) P/B ratio 7.58
Dividend yield 0.51%
Last dividend (FY24) CHF0.69
Revenue growth (TTM) Revenue growth 15.62%
Revenue (TTM) Revenue CHF553.77m
EBIT (operating result TTM) EBIT CHF88.72m
Free Cash Flow (TTM) Free Cash Flow CHF2.30m
Cash position CHF34.02m
EPS (TTM) EPS CHF3.42
P/E forward 34.26
P/S forward 4.36
EV/Sales forward 4.67
Show more

Is Medacta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Medacta Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Medacta forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Medacta forecast:

Buy
86%
Hold
14%

Financial data from Medacta

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
554 554
16% 16%
100%
- Direct Costs 179 179
17% 17%
32%
375 375
15% 15%
68%
- Selling and Administrative Expenses 267 267
13% 13%
48%
- Research and Development Expense 19 19
3% 3%
3%
150 150
19% 19%
27%
- Depreciation and Amortization 62 62
13% 13%
11%
EBIT (Operating Income) EBIT 89 89
24% 24%
16%
Net Profit 68 68
54% 54%
12%

In millions CHF.

Don't miss a Thing! We will send you all news about Medacta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medacta Stock News

AD HOC NEWS
about one month ago
Medacta Group SA / CH0468525222
AD HOC NEWS
2 months ago
Medacta Group SA / CH0468525222

Company Profile

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Rest of the World. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.

Head office Switzerland
CEO Francesco Siccardi
Employees 1,907
Founded 1999
Website www.medacta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today